{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T21:09:57Z","timestamp":1758056997530,"version":"3.44.0"},"reference-count":15,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["L'Enc\u00e9phale"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.encep.2022.03.003","type":"journal-article","created":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T22:40:35Z","timestamp":1655505635000},"page":"199-201","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Pr\u00e9gabaline sous la loupe carc\u00e9rale. R\u00e9flexions sur une probl\u00e9matique \u00e9mergente"],"prefix":"10.1016","volume":"49","author":[{"given":"D.","family":"Marcot","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.C.","family":"Castelan Camargo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.encep.2022.03.003_bib0080","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s40265-017-0700-x","article-title":"Abuse and misuse of pregabalin and gabapentin","volume":"77","author":"Evoy","year":"2017","journal-title":"Drugs"},{"key":"10.1016\/j.encep.2022.03.003_bib0085","unstructured":"https:\/\/compendium.ch\/product\/1301641-pregabaline-sandoz-caps-25-mg\/mpro acc\u00e9d\u00e9 le 09.09.2021."},{"key":"10.1016\/j.encep.2022.03.003_bib0090","unstructured":"https:\/\/www.has-sante.fr\/jcms\/c_2771881\/en\/lyrica acc\u00e9d\u00e9 le 09.09.2021."},{"issue":"7","key":"10.1016\/j.encep.2022.03.003_bib0095","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1111\/add.13324","article-title":"Gabapentin misuse, abuse and diversion: a systematic review","volume":"111","author":"Smith","year":"2016","journal-title":"Addiction"},{"key":"10.1016\/j.encep.2022.03.003_bib0100","first-page":"12147","article-title":"Associations between gabapentinoids and suicidal behaviour, unintentional overdoses, injuries, road traffic incidents, and violent crime: population based cohort study in Sweden","volume":"365","author":"Molero","year":"2019","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.encep.2022.03.003_bib0105","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1056\/NEJMp0808659","article-title":"The Neurontin legacy--marketing through misinformation and manipulation","volume":"60","author":"Landefeld","year":"2009","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.encep.2022.03.003_bib0110","first-page":"43425","article-title":"Pregabalin-associated discontinuation symptoms: a case report","volume":"10","author":"Naveed","year":"2018","journal-title":"Cureus"},{"key":"10.1016\/j.encep.2022.03.003_bib0115","unstructured":"https:\/\/ansm.sante.fr\/informations-de-securite\/nouvelles-conditions-de-prescription-et-de-delivrance-des-specialites-a-base-de-pregabaline-lyrica-et-ses-generiques acc\u00e9d\u00e9 le 09.09.2021."},{"key":"10.1016\/j.encep.2022.03.003_bib0120","unstructured":"https:\/\/www.youtube.com\/watch?v=8fc8sXWopBs acc\u00e9d\u00e9 le 09.09.2021."},{"issue":"1","key":"10.1016\/j.encep.2022.03.003_bib0125","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s12991-014-0037-8","article-title":"Depression and attempted suicide under pregabalin therapy","volume":"13","author":"Kustermann","year":"2014","journal-title":"Ann Gen Psychiatry"},{"key":"10.1016\/j.encep.2022.03.003_bib0130","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1891\/ehppij-v8i3a003","article-title":"Intoxication anosognosia: the spellbinding effect of psychiatric drugs","volume":"8","author":"Breggin","year":"2006","journal-title":"Ethical Human Psychology and Psychiatry"},{"issue":"3","key":"10.1016\/j.encep.2022.03.003_bib0135","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3917\/esp.162.0031","article-title":"\u00ab\u00a0Exp\u00e9riences plurielles de l\u2019enfermement: entre rejet et reprise de contr\u00f4le\u00a0\u00bb","volume":"162","author":"Gouvernet","year":"2015","journal-title":"Espaces et soci\u00e9t\u00e9s"},{"issue":"10","key":"10.1016\/j.encep.2022.03.003_bib0140","doi-asserted-by":"crossref","first-page":"474","DOI":"10.5694\/mja2.50398","article-title":"Management of pregabalin and gabapentin prescribing and use in NSW prisons","volume":"211","author":"Nicholls","year":"2019","journal-title":"Med J Aust"},{"key":"10.1016\/j.encep.2022.03.003_bib0145","unstructured":"https:\/\/bulger.co.uk\/prison\/RCGPsaferprescribinginprisons2019.pdf acc\u00e9d\u00e9 le 26.02.2022."},{"issue":"12","key":"10.1016\/j.encep.2022.03.003_bib0075","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/j.euroneuro.2017.08.430","article-title":"How addictive are gabapentin and pregabalin? A systematic review","volume":"27","author":"Bonnet","year":"2017","journal-title":"Eur Neuropsychopharmacol"}],"container-title":["L'Enc\u00e9phale"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0013700622001051?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0013700622001051?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T17:43:24Z","timestamp":1757958204000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0013700622001051"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":15,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["S0013700622001051"],"URL":"https:\/\/doi.org\/10.1016\/j.encep.2022.03.003","relation":{},"ISSN":["0013-7006"],"issn-type":[{"type":"print","value":"0013-7006"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pr\u00e9gabaline sous la loupe carc\u00e9rale. R\u00e9flexions sur une probl\u00e9matique \u00e9mergente","name":"articletitle","label":"Article Title"},{"value":"L'Enc\u00e9phale","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.encep.2022.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 L'Enc\u00e9phale, Paris.","name":"copyright","label":"Copyright"}]}}